We provide you with 20 years of free, institutional-grade data for BNR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BNR. Explore the full financial landscape of BNR stock.
| Reported Date | CIK | Ticker | Type |
|---|
Burning Rock Biotech Limited(NASDAQ:BNR) 
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Website: http://www.brbiotech.com
Founded: 2014
Full Time Employees: 705
CEO: Yu Sheng Han
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
The information provided in this report about BNR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.